TNXP (STOCKS)
Tonix Pharmaceuticals Holding Corp.
$15.500000
-0.410000 (-2.58%)
Prev close: $15.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Seth Lederman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $202.95M
- Employees
- 81
- P/E (TTM)
- -0.02
- P/B (TTM)
- 0.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $10.30M |
| Benefits Costs and Expenses | $110.20M |
| Cost Of Revenue | $6.77M |
| Costs And Expenses | $110.20M |
| Gross Profit | $3.53M |
| Operating Expenses | $103.43M |
| Selling, General, and Administrative Expenses | $67.59M |
| Depreciation and Amortization | $1.90M |
| Research and Development | $35.84M |
| Operating Income/Loss | -$99.90M |
| Income/Loss From Continuing Operations After Tax | -$99.22M |
| Income/Loss From Continuing Operations Before Tax | -$100.65M |
| Net Income/Loss | -$99.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$99.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$99.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $279.28 |
| Diluted Earnings Per Share | $279.28 |
| Basic Average Shares | 22,682,096 |
| Diluted Average Shares | 22,682,096 |
| Assets | $252.44M |
| Current Assets | $208.07M |
| Noncurrent Assets | $44.37M |
| Fixed Assets | $42.57M |
| Intangible Assets | $120.00K |
| Other Non-current Assets | $1.68M |
| Liabilities | $21.30M |
| Current Liabilities | $21.03M |
| Accounts Payable | $8.54M |
| Other Current Liabilities | $12.49M |
| Noncurrent Liabilities | $266.00K |
| Equity | $231.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $231.14M |
| Liabilities And Equity | $252.44M |
| Net Cash Flow From Operating Activities | -$74.82M |
| Net Cash Flow From Operating Activities, Continuing | -$74.82M |
| Net Cash Flow From Investing Activities | -$3.51M |
| Net Cash Flow From Investing Activities, Continuing | -$3.51M |
| Net Cash Flow From Financing Activities | $240.54M |
| Net Cash Flow From Financing Activities, Continuing | $240.54M |
| Exchange Gains/Losses | $7.00K |
| Net Cash Flow | $162.21M |
| Net Cash Flow, Continuing | $162.21M |
| Comprehensive Income/Loss | -$99.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$99.24M |
| Other Comprehensive Income/Loss | -$54.13M |